Zhi-Dong Jiang

发表

Improvement in detection of enterotoxigenic Escherichia coli in patients with travelers' diarrhea by increasing the number of E. coli colonies tested.

H. Dupont, Don Thushara Galbadage, Zhi-Dong Jiang, 2009, The American journal of tropical medicine and hygiene.

Multidrug Resistance Is Common in Escherichia coli Associated with Ileal Crohn's Disease

R. Yantiss, H. Dupont, P. Garneau, 2013, Inflammatory bowel diseases.

Stability and efficacy of frozen and lyophilized fecal microbiota transplant (FMT) product in a mouse model of Clostridium difficile infection (CDI).

H. Dupont, Zhi-Dong Jiang, A. Alexander, 2017, Anaerobe.

In Vitro Activity and Fecal Concentration of Rifaximin after Oral Administration

E. Palazzini, L. Riopel, Zhi-Dong Jiang, 2000, Antimicrobial Agents and Chemotherapy.

Therapy of travelers’ diarrhea with rifaximin on various continents

B. Lowe, D. Sack, H. Dupont, 2003, American Journal of Gastroenterology.

Enteroaggregative Escherichia coli diarrhea in travelers: response to rifaximin therapy.

D. Sack, H. Dupont, R. Steffen, 2004, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Efficacy and safety of a patch vaccine containing heat-labile toxin from Escherichia coli against travellers' diarrhoea: a phase 3, randomised, double-blind, placebo-controlled field trial in travellers from Europe to Mexico and Guatemala.

D. Stablein, H. Dupont, G. Glenn, 2014, The Lancet. Infectious diseases.

Bioactive fungal natural products through classic and biocombinatorial approaches

Zhi-Dong Jiang, Zhiqiang An, 2000 .

Epidemiology of cryptosporidiosis in North American travelers to Mexico.

H. Dupont, P. Okhuysen, Zhi-Dong Jiang, 2007, The American journal of tropical medicine and hygiene.

New advances in Clostridium difficile infection: changing epidemiology, diagnosis, treatment and control

J. Caeiro, K. Garey, H. Dupont, 2008, Current opinion in infectious diseases.

Treatment of Recurrent Carotid Disease

J. Howell, Zhi-Dong Jiang, K. Plestis, 1997 .

Evaluation of Six Weekly Oral Fecal Microbiota Transplants in People with HIV

A. Somasunderam, H. Dupont, J. Lake, 2020, Pathogens & immunity.

for treatment of travellers’ diarrhea: equally effective as ciprofloxacin and not associated with the acquisition of multi-drug resistant bacteria

H. Dupont, R. Steffen, R. Greinwald, 2018 .

Colonic Immunopathogenesis of Clostridium difficile Infections

K. Garey, H. Dupont, Zhi-Dong Jiang, 2014, Clinical and Vaccine Immunology.

Low-Income Minority Women at Risk for Cervical Cancer: A Process to Improve Adherence to Follow-up Recommendations

Zhi-Dong Jiang, R. Grimes, V. Cardin, 2001, Public health reports.

A single-nucleotide polymorphism in the gene encoding osteoprotegerin, an anti-inflammatory protein produced in response to infection with diarrheagenic Escherichia coli, is associated with an increased risk of nonsecretory bacterial diarrhea in North American travelers to Mexico.

H. Dupont, A. White, P. Okhuysen, 2009, The Journal of infectious diseases.

A Hospital-based Study of the Clinical Characteristics of Clostridium difficile Infection in Children

H. Dupont, Zhi-Dong Jiang, J. Starke, 2014, The Pediatric infectious disease journal.

Visualization-assisted binning of metagenome assemblies reveals potential new pathogenic profiles in idiopathic travelers’ diarrhea

S. Highlander, Qiyun Zhu, H. Dupont, 2018, Microbiome.

Single nucleotide polymorphisms in the promoter of the gene encoding the lipopolysaccharide receptor CD14 are associated with bacterial diarrhea in US and Canadian travelers to Mexico.

H. Dupont, P. Okhuysen, Zhi-Dong Jiang, 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Development and accuracy of quantitative real-time polymerase chain reaction assays for detection and quantification of enterotoxigenic Escherichia coli (ETEC) heat labile and heat stable toxin genes in travelers' diarrhea samples.

N. Ajami, J. Petrosino, Bonnie P. Youmans, 2014, The American journal of tropical medicine and hygiene.

A randomized, double-blind, pilot study of rifaximin 550 mg versus placebo in the prevention of travelers' diarrhea in Mexico during the dry season.

H. Dupont, P. Okhuysen, Zhi-Dong Jiang, 2011, Journal of travel medicine.

Bile Acids Improve the Antimicrobial Effect of Rifaximin

N. Ajami, H. Dupont, L. Lichtenberger, 2010, Antimicrobial Agents and Chemotherapy.

Rifaximin-induced alteration of virulence of diarrhoea-producing Escherichia coli and Shigella sonnei.

H. Dupont, Zhi-Dong Jiang, S. Ke, 2010, International journal of antimicrobial agents.

Enterotoxigenic Escherichia coli heat-labile toxin seroconversion in US travelers to Mexico.

H. Dupont, P. Okhuysen, Zhi-Dong Jiang, 2008, Journal of travel medicine.

Azithromycin found to be comparable to levofloxacin for the treatment of US travelers with acute diarrhea acquired in Mexico.

H. Dupont, C. Knirsch, Zhi-Dong Jiang, 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

PCR-Based Assay Using Occult Blood Detection Cards for Detection of Diarrheagenic Escherichia coli in Specimens from U.S. Travelers to Mexico with Acute Diarrhea

H. Dupont, P. Okhuysen, Zhi-Dong Jiang, 2008, Journal of Clinical Microbiology.

Author Correction: Fecal microbiota transplantation for refractory immune checkpoint inhibitor-associated colitis

B. Helmink, J. Wargo, P. Sharma, 2018, Nature Medicine.

A randomized, double-blind, multicenter study of rifaximin compared with placebo and with ciprofloxacin in the treatment of travelers' diarrhea.

H. Dupont, R. Steffen, A. L. Bourgeois, 2006, The American journal of tropical medicine and hygiene.

In Vitro Antimicrobial Susceptibility Testing of Bacterial Enteropathogens Causing Traveler's Diarrhea in Four Geographic Regions

B. Lowe, H. Dupont, R. Steffen, 2001, Antimicrobial Agents and Chemotherapy.

Occurrence of putative virulence-related genes, aatA, aggR and aaiC, of Enteroaggregative Escherichia coli (EAEC) among adults with travelers' diarrhea acquired in Guatemala and Mexico.

H. Dupont, Zhi-Dong Jiang, O. Bamidele, 2019, Microbial pathogenesis.

A randomized, double-blind, placebo-controlled pilot study to assess the ability of rifaximin to prevent recurrent diarrhoea in patients with Clostridium difficile infection.

K. Garey, Maki Habib, H. Dupont, 2011, The Journal of antimicrobial chemotherapy.

Changing Clostridium difficile infection testing and treatment trends at a large tertiary care teaching hospital

K. Garey, T. Dao-Tran, H. Dupont, 2009, Pharmacy World & Science.

Clostridium difficile infection in patients with ileal pouch-anal anastomosis.

H. Dupont, V. Fazio, F. Remzi, 2008, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Treatment of travelers' diarrhea: randomized trial comparing rifaximin, rifaximin plus loperamide, and loperamide alone.

H. Dupont, David N. Taylor, P. Okhuysen, 2007, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Rifaximin treatment of pathogen-negative travelers' diarrhea.

H. Dupont, David N. Taylor, R. Steffen, 2007, Journal of travel medicine.

Rate of Occurrence and Pathogenic Effect of Enteroaggregative Escherichia coli Virulence Factors in International Travelers

H. Dupont, D. Greenberg, J. Nataro, 2002, Journal of Clinical Microbiology.

Natural history of enteroaggregative and enterotoxigenic Escherichia coli infection among US travelers to Guadalajara, Mexico.

H. Dupont, Zhi-Dong Jiang, C. Ericsson, 2002, The Journal of infectious diseases.

United States male students who heavily consume alcohol in Mexico are at greater risk of travelers' diarrhea than their female counterparts.

H. Dupont, Zhi-Dong Jiang, C. Ericsson, 2006, Journal of travel medicine.

Virulence characteristics and the molecular epidemiology of enteroaggregative Escherichia coli isolates from travellers to developing countries.

H. Dupont, J. Nataro, P. Okhuysen, 2007, Journal of medical microbiology.

Coliform and Escherichia coli contamination of desserts served in public restaurants from Guadalajara, Mexico, and Houston, Texas.

H. Dupont, E. Brown, Don Thushara Galbadage, 2009, The American journal of tropical medicine and hygiene.

Interleukin-8 Response in an Intestinal HCT-8 Cell Line Infected with Enteroaggregative and Enterotoxigenic Escherichia coli

H. Dupont, P. Okhuysen, Zhi-Dong Jiang, 2004, Clinical Diagnostic Laboratory Immunology.

Enteroaggregative Escherichia coli: An Emerging Enteric Pathogen

H. Dupont, P. Okhuysen, Zhi-Dong Jiang, 2004, American Journal of Gastroenterology.

Evaluation of Escherichia coli pathotypes associated with irritable bowel syndrome

H. Dupont, B. Dogan, E. Scherl, 2018, FEMS microbiology letters.

Identification of compounds that inhibit late steps of peptidoglycan synthesis in bacteria.

P. Youngman, M. Hickey, D. Rothstein, 2002, The Journal of antibiotics.

Biochemical and genetic diversity of enterotoxigenic Escherichia coli associated with diarrhea in United States students in Cuernavaca and Guadalajara, Mexico, 2004-2007.

N. Ajami, H. Dupont, P. Okhuysen, 2010, The Journal of infectious diseases.

CONCISE COMMUNICATIONS Improved Detection of Enterotoxigenic Escherichia coli among Patients with Travelers’ Diarrhea, by Use of the Polymerase Chain Reaction Technique

J. Caeiro, H. Dupont, R. Steffen, 1999 .

Microbial Etiology of Travelers' Diarrhea in Mexico, Guatemala, and India: Importance of Enterotoxigenic Bacteroides fragilis and Arcobacter Species

H. Dupont, R. K. Nandy, Santanu Ghosh, 2010, Journal of Clinical Microbiology.

Association of virulence factor-positive and -negative enteroaggregative Escherichia coli and occurrence of clinical illness in travelers from the United States to Mexico.

H. Dupont, Zhi-Dong Jiang, David B. Huang, 2003, The American journal of tropical medicine and hygiene.

Colonization Factors in Enterotoxigenic Escherichia coli Strains in Travelers to Mexico, Guatemala, and India Compared with Children in Houston, Texas.

H. Dupont, Zhi-Dong Jiang, M. Riddle, 2017, The American journal of tropical medicine and hygiene.

Use of a patch containing heat-labile toxin from Escherichia coli against travellers' diarrhoea: a phase II, randomised, double-blind, placebo-controlled field trial

H. Dupont, G. Glenn, P. Okhuysen, 2008, The Lancet.

Prevalence of enteric pathogens among international travelers with diarrhea acquired in Kenya (Mombasa), India (Goa), or Jamaica (Montego Bay).

B. Lowe, H. Dupont, R. Steffen, 2002, The Journal of infectious diseases.

Targeting of rifamycin SV to the colon for treatment of travelers' diarrhea: a randomized, double-blind, placebo-controlled phase 3 study.

R. Bagin, H. Dupont, L. Moro, 2014, Journal of travel medicine.

Safety and efficacy of fecal microbiota transplantation to treat and prevent recurrent Clostridioides difficile in cancer patients

H. Dupont, P. Okhuysen, Zhi-Dong Jiang, 2021, Journal of Cancer.

Persistent abdominal symptoms in US adults after short-term stay in Mexico.

H. Dupont, P. Okhuysen, Zhi-Dong Jiang, 2014, Journal of travel medicine.

Prevention of travelers' diarrhea with rifaximin in US travelers to Mexico.

H. Dupont, E. Bortey, W. Forbes, 2010, Journal of travel medicine.

Antibacterial chemoprophylaxis in the prevention of traveler's diarrhea: evaluation of poorly absorbed oral rifaximin.

H. Dupont, P. Okhuysen, Zhi-Dong Jiang, 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Enterotoxigenic Escherichia coli as cause of diarrhea among Mexican adults and US travelers in Mexico.

H. Dupont, A. Bouckenooghe, Zhi-Dong Jiang, 2006, Journal of travel medicine.

Seroepidemiology of norovirus-associated travelers' diarrhea.

N. Ajami, M. Estes, H. Dupont, 2014, Journal of travel medicine.

Enteric Pathogens in Mexican Sauces of Popular Restaurants in Guadalajara, Mexico, and Houston, Texas

H. Dupont, J. Mathewson, Zhi-Dong Jiang, 2002, Annals of Internal Medicine.

Noroviruses as a Cause of Diarrhea in Travelers to Guatemala, India, and Mexico

N. Ajami, H. Dupont, David N. Taylor, 2007, Journal of Clinical Microbiology.

Rifamycin SV-MMX® for treatment of travellers’ diarrhea: equally effective as ciprofloxacin and not associated with the acquisition of multi-drug resistant bacteria

H. Dupont, R. Steffen, R. Greinwald, 2018, Journal of travel medicine.

In Vitro Antimicrobial Susceptibility of Bacterial Enteropathogens Isolated from International Travelers to Mexico, Guatemala, and India from 2006 to 2008

H. Dupont, R. K. Nandy, R. Steffen, 2010, Antimicrobial Agents and Chemotherapy.

Travel and travelers' diarrhea in patients with irritable bowel syndrome.

H. Dupont, F. García‐Torres, Zhi-Dong Jiang, 2010, The American journal of tropical medicine and hygiene.

Enterotoxigenic Escherichia coli and diffusely adherent E. coli as likely causes of a proportion of pathogen-negative travelers' diarrhea--a PCR-based study.

H. Dupont, David N. Taylor, R. Steffen, 2008, Journal of travel medicine.

Markers of inflammation in bacterial diarrhea among travelers, with a focus on enteroaggregative Escherichia coli pathogenicity.

H. Dupont, D. Greenberg, R. Steffen, 2002, The Journal of infectious diseases.

Fecal cytokines and markers of intestinal inflammation in international travelers with diarrhea due to Noroviruses

H. Dupont, P. Okhuysen, Zhi-Dong Jiang, 2006, Journal of medical virology.

Actinoflavoside, a novel flavonoid-like glycoside produced by a marine bacterium of the genus Streptomyces

P. Jensen, W. Fenical, Zhi-Dong Jiang, 1997 .

Novel oxylipins from the temperate red alga polyneura latissima: Evidence for an arachidonate 9(S)-lipoxygenase

W. Gerwick, Zhi-Dong Jiang, 1997, Lipids.

A Case of Successful Treatment of Recurrent Urinary Tract Infection by Extended-Spectrum β-Lactamase Producing Klebsiella pneumoniae Using Oral Lyophilized Fecal Microbiota Transplant.

H. Dupont, C. Arias, B. Hanson, 2022, Microbial drug resistance.

Rifaximin Resistance in Escherichia coli Associated with Inflammatory Bowel Disease Correlates with Prior Rifaximin Use, Mutations in rpoB, and Activity of Phe-Arg-β-Naphthylamide-Inhibitable Efflux Pumps

H. Dupont, J. Harel, B. Dogan, 2012, Antimicrobial Agents and Chemotherapy.

HEp-2 Cell-Adherent Escherichia coli and Intestinal Secretory Immune Response to Human Immunodeficiency Virus (HIV) in Outpatients with HIV-Associated Diarrhea

H. Dupont, R. Arduino, J. Mathewson, 1998, Clinical Diagnostic Laboratory Immunology.

Association of Putative Enteroaggregative Escherichia coli Virulence Genes and Biofilm Production in Isolates from Travelers to Developing Countries

H. Dupont, J. Nataro, P. Okhuysen, 2006, Journal of Clinical Microbiology.

A Randomized, Double-Blind, Placebo-Controlled Trial of Rifaximin To Prevent Travelers' Diarrhea

H. Dupont, P. Okhuysen, Zhi-Dong Jiang, 2005, Annals of Internal Medicine.

Post-Diarrhea Chronic Intestinal Symptoms and Irritable Bowel Syndrome in North American Travelers to Mexico

H. Dupont, P. Okhuysen, Zhi-Dong Jiang, 2004, The American Journal of Gastroenterology.

Genetic susceptibility to enteroaggregative Escherichia coli diarrhea: polymorphism in the interleukin-8 promotor region.

D. Milewicz, D. Guo, H. Dupont, 2003, The Journal of infectious diseases.

Peripartum Clostridium difficile infection: case series and review of the literature.

K. Garey, H. Dupont, Zhi-Dong Jiang, 2008, American journal of obstetrics and gynecology.

Coliform contamination of vegetables obtained from popular restaurants in Guadalajara, Mexico, and Houston, Texas.

H. Dupont, E. Brown, Zhi-Dong Jiang, 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Campylobacter jejuni is not an important pathogen as a cause of diarrhea in US travelers to Mexico.

H. Dupont, P. Okhuysen, Zhi-Dong Jiang, 2011, Journal of travel medicine.

Characterization of the human gut microbiome during travelers' diarrhea

N. Ajami, J. Petrosino, Bonnie P. Youmans, 2015, Gut microbes.

Rifaximin versus Ciproﬂoxacin for the Treatment of Traveler’s Diarrhea: A Randomized, Double-Blind Clinical Trial

H. Dupont, E. Palazzini, L. Riopel, 2001 .

Three new and bioactive icosanoids from the temperate red marine algaFarlowia mollis

W. Gerwick, Zhi-Dong Jiang, M. Solem, 1989, Lipids.

Eicosanoids and other hydroxylated fatty acids from the marine alga Gracilariopsis lemaneiformis

W. Gerwick, Zhi-Dong Jiang, 1991 .

Intestinal decontamination inhibits TLR4 dependent fibronectin-mediated cross-talk between stellate cells and endothelial cells in liver fibrosis in mice.

Douglas A. Simonetto, V. Shah, H. Dupont, 2012, Journal of hepatology.

Galactolipids from the temperate red marine alga Gracilariopsis lemaneiformis

W. Gerwick, Zhi-Dong Jiang, 1990 .

Epidemiology of travelers' diarrhea in Thailand.

V. Chongsuvivatwong, H. Dupont, R. Steffen, 2009, Journal of travel medicine.

Loperamide plus azithromycin more effectively treats travelers' diarrhea in Mexico than azithromycin alone.

H. Dupont, P. Okhuysen, Zhi-Dong Jiang, 2007, Journal of travel medicine.

Physician attitudes toward the use of fecal transplantation for recurrent Clostridium difficile infection in a metropolitan area.

K. Garey, H. Dupont, Zhi-Dong Jiang, 2013, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Eicosanoids from the Rhodophyta: new metabolism in the algae

W. Gerwick, M. Moghaddam, D. Nagle, 1990, Hydrobiologia.

A novel single-nucleotide polymorphism in the lactoferrin gene is associated with susceptibility to diarrhea in North American travelers to Mexico.

H. Dupont, L. Armitige, P. Okhuysen, 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Fecal microbiota transplantation for refractory immune checkpoint inhibitor-associated colitis

B. Helmink, J. Wargo, P. Sharma, 2018, Nature Medicine.

Fecal microbiota transplantation for refractory immune checkpoint inhibitor-associated colitis

B. Helmink, J. Wargo, P. Sharma, 2018, Nature Medicine.

A common polymorphism in the interleukin-8 gene promoter is associated with an increased risk for recurrent Clostridium difficile infection.

V. Tam, K. Garey, H. Dupont, 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

A Common Polymorphism in the Interleukin 8 Gene Promoter Is Associated with Clostridium difficile Diarrhea

M. Larocco, K. Garey, T. Dao-Tran, 2006, The American Journal of Gastroenterology.

Safety and preliminary efficacy of orally administered lyophilized fecal microbiota product compared with frozen product given by enema for recurrent Clostridium difficile infection: A randomized clinical trial

Christine B. Peterson, N. Ajami, J. Petrosino, 2018, PloS one.

Real-Time Polymerase Chain Reaction Detection of Asymptomatic Clostridium difficile Colonization and Rising C. difficile–Associated Disease Rates1

K. Garey, H. Dupont, P. Revell, 2014, Infection Control & Hospital Epidemiology.

Fecal microbiota transplantation (FMT) for immune checkpoint inhibitor induced–colitis (IMC) refractory to immunosuppressive therapy.

H. Dupont, Zhi-Dong Jiang, Hamzah Abu-Sbeih, 2020 .

Use of Rifamycin Drugs and Development of Infection by Rifamycin-Resistant Strains of Clostridium difficile

K. Garey, H. Dupont, Zhi-Dong Jiang, 2013, Antimicrobial Agents and Chemotherapy.

Clostridium difficile infection: update on emerging antibiotic treatment options and antibiotic resistance

Dhara Shah, Herbert L DuPont, Kevin W Garey, 2010, Expert review of anti-infective therapy.

WITHDRAWN: In vitro activity of rifaximin and rifampin against clinical isolates of clostridium difficile in houston, texas.

K. Garey, H. Dupont, Zhi-Dong Jiang, 2009, Anaerobe.

Rifaximin in Treatment of Recurrent Clostridium difficile-associated Diarrhea: An Uncontrolled Pilot Study

K. Garey, H. Dupont, Zhi-Dong Jiang, 2009, Journal of clinical gastroenterology.

Abnormal Intestinal Microbiome in Medical Disorders and Potential Reversibility by Fecal Microbiota Transplantation

H. Dupont, Zhi-Dong Jiang, N. Utay, 2020, Digestive Diseases and Sciences.

THE INTESTINAL MICROBIOME IN HUMAN HEALTH AND DISEASE.

H. Dupont, Zhi-Dong Jiang, N. Utay, 2020, Transactions of the American Clinical and Climatological Association.

Clostridium difficile infection in diabetes.

H. Qu, Zhi-Dong Jiang, 2014, Diabetes research and clinical practice.

Association of interleukin-8 polymorphism and immunoglobulin G anti-toxin A in patients with Clostridium difficile-associated diarrhea.

M. Larocco, K. Garey, T. Dao-Tran, 2007, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Prevalence of Diarrhea at a University Hospital and Association with Modifiable Risk Factors

Laura N. Gerard, K. Garey, M. Price, 2006, The Annals of pharmacotherapy.

A nosocomial outbreak of norovirus infection masquerading as clostridium difficile infection.

E. J. Young, N. Ajami, D. Musher, 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Erratum: A randomized, double-blind, placebo-controlled trial of rifaximin to prevent travelers' diarrhea (Annals of Internal Medicine (2005) 142 (805-812))

H. Dupont, P. Okhuysen, Zhi-Dong Jiang, 2005 .

Noroviruses as a Cause of Traveler's Diarrhea among Students from the United States Visiting Mexico

R. Glass, H. Dupont, P. Okhuysen, 2005, Journal of Clinical Microbiology.

Total structure of hormothamnin A, a toxic cyclic undecapeptide from the tropical marine cyanobacterium Hormothamnion enteromorphoides

B. Farmer, W. Gerwick, Zhi-Dong Jiang, 1992 .

Efficacy of a travelers' diarrhea vaccine system in travelers to India.

H. Dupont, T. Jelínek, R. Steffen, 2013, Journal of travel medicine.

S156 Microbiome Alteration via Fecal Microbiota Transplantation (FMT) Is Effective for Immune Checkpoint Inhibitor (ICI) Induced-Colitis (IMC) Refractory to Immunosuppressive Therapy

R. Jenq, Zhi-Dong Jiang, Yinghong Wang, 2021, American Journal of Gastroenterology.

Pretreatment of Epithelial Cells with Rifaximin Alters Bacterial Attachment and Internalization Profiles

H. Dupont, E. Brown, Qiong Xue, 2009, Antimicrobial Agents and Chemotherapy.

Motility Abnormalities in Irritable Bowel Syndrome

H. Dupont, F. García‐Torres, Zhi-Dong Jiang, 2014, Digestion.

Intestinal IgA-Coated Bacteria in Healthy- and Altered-Microbiomes (Dysbiosis) and Predictive Value in Successful Fecal Microbiota Transplantation

H. Dupont, E. Brown, Zhi-Dong Jiang, 2022, Microorganisms.

IgA-Biome Profiles Correlate with Clinical Parkinson’s Disease Subtypes

S. Safari, H. Dupont, C. Hanis, 2023, Journal of Parkinson's disease.

Visualization-assisted binning of metagenome assemblies reveals potential new pathogenic profiles in idiopathic travelers’ diarrhea

S. Highlander, Qiyun Zhu, H. Dupont, 2018, Microbiome.

A Mouse Model of Clostridium difficile Infection (CDI) Suitable for Study of Human Fecal Microbiota Transplantation (FMT): 1320

H. Dupont, Zhi-Dong Jiang, S. Ke, 2015 .

Fresh, Frozen, or Lyophilized Fecal Microbiota Transplantation (FMT) for Multiple Recurrent C. difficile Infection (CDI): 734

N. Ajami, J. Petrosino, H. Dupont, 2014 .

Fecal microbiota transplantation in Parkinson's disease—A randomized repeat-dose, placebo-controlled clinical pilot study

H. Dupont, E. Brown, Tehseen Iqbal, 2023, Frontiers in Neurology.

Fecal Calprotectin in the Diagnosis of Clostridium difficile Infection

K. Garey, H. Dupont, Zhi-Dong Jiang, 2016 .

Phylogenetic Comparisons Reveal Multiple Acquisitions of the Toxin Genes by Enterotoxigenic Escherichia coli Strains of Different Evolutionary Lineages

M. Pallen, R. Chaudhuri, I. Henderson, 2006, Journal of Clinical Microbiology.

Microbiome alteration via fecal microbiota transplantation is effective for refractory immune checkpoint inhibitor–induced colitis

R. Jenq, H. Dupont, Chia-Chi Chang, 2023, Science Translational Medicine.

Combined Carotid Endarterectomy and Coronary Artery Bypass: Immediate and Long-Term Results

J. Howell, Zhi-Dong Jiang, K. Plestis, 1999, Annals of vascular surgery.

Recurrent Clostridium difficile Infection in Children: Patient Risk Factors and Markers of Intestinal Inflammation

K. Edwards, H. Dupont, Zhi-Dong Jiang, 2017, The Pediatric infectious disease journal.

Detection of Enteroaggregative Escherichia coli with Formalin-Preserved HEp-2 Cells

H. Dupont, J. Nataro, M. Miqdady, 2002, Journal of Clinical Microbiology.

Intestinal Secretory Immunoglobulin A Response to Enteroaggregative Escherichia coli in Travelers with Diarrhea

H. Dupont, A. Bouckenooghe, J. Mathewson, 2000, Clinical Diagnostic Laboratory Immunology.

Emergence of trimethoprim-resistant Escherichia coli in healthy persons in the absence of prophylactic or therapeutic antibiotics during travel to Guadalajara, Mexico.

Z. Jiang, H. Dupont, Zhi-Dong Jiang, 2001, Scandinavian journal of infectious diseases.

Enteroaggregative Escherichia coli as a major etiologic agent in traveler's diarrhea in 3 regions of the world.

Z. Jiang, H. Dupont, R. Steffen, 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Randomised clinical trial: faecal microbiota transplantation for recurrent Clostridum difficile infection – fresh, or frozen, or lyophilised microbiota from a small pool of healthy donors delivered by colonoscopy

N. Ajami, J. Petrosino, Z. Jiang, 2017, Alimentary pharmacology & therapeutics.

Characterization of norovirus-associated traveler's diarrhea.

N. Ajami, H. Dupont, R. Atmar, 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Etiology of outpatient pediatric nondysenteric diarrhea: a multicenter study in the United States.

J. Caeiro, Z. Jiang, H. Dupont, 1999, The Pediatric infectious disease journal.

In vitro susceptibility of Clostridium difficile to rifaximin and rifampin in 359 consecutive isolates at a university hospital in Houston, Texas

K. Garey, H. Dupont, N. Khardori, 2010, Journal of Clinical Pathology.

Rifaximin: In vitro and in vivo Antibacterial Activity – A Review

H. Dupont, Zhi-Dong Jiang, Z. Jiang, 2005, Chemotherapy.

Tu1019 - The Effect of type of Inoculum and Administration Route of Fecal Microbiotatransplantation in Subjects with Recurrent Clostridium Difficile Infection (CDI)

N. Ajami, R. Jenq, H. Dupont, 2018 .

Lyophilized Fecal Microbiota Transplantation Capsules for Recurrent Clostridium difficile Infection

N. Ajami, J. Petrosino, G. Jun, 2017, Open Forum Infectious Diseases.

Rifaximin versus ciprofloxacin for the treatment of traveler's diarrhea: a randomized, double-blind clinical trial.

Z. Jiang, H. Dupont, E. Palazzini, 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

H. Dupont, J. Harel, B. Dogan, 2012, Antimicrobial Agents and Chemotherapy.

Bile Acids Improve the Antimicrobial Effect of Rifaximin

N. Ajami, H. Dupont, L. Lichtenberger, 2010, Antimicrobial Agents and Chemotherapy.

Influence of rifaximin treatment on the susceptibility of intestinal Gram-negative flora and enterococci.

H. Dupont, Zhi-Dong Jiang, Z. Jiang, 2004, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Rifaximin: A Nonabsorbed Antimicrobial in the Therapy of Travelers’ Diarrhea

H. Dupont, E. Palazzini, J. Mathewson, 1998, Digestion.

Coliform and Escherichia coli contamination of desserts served in public restaurants from Guadalajara, Mexico, and Houston, Texas.

H. Dupont, E. Brown, Don Thushara Galbadage, 2009, The American journal of tropical medicine and hygiene.

Coliform contamination of vegetables obtained from popular restaurants in Guadalajara, Mexico, and Houston, Texas.

H. Dupont, E. Brown, Zhi-Dong Jiang, 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Changing Clostridium difficile infection testing and treatment trends at a large tertiary care teaching hospital

K. Garey, H. Dupont, Zhi-Dong Jiang, 2009, Pharmacy World & Science.

P. Okhuysen, Zhi-Dong Jiang, J. Belkind-Gerson, 2009, The Journal of infectious diseases.

Characterization of enterotoxigenic Escherichia coli strains in patients with travelers' diarrhea acquired in Guadalajara, Mexico, 1992-1997.

H. Dupont, A. Svennerholm, J. Mathewson, 2000, The Journal of infectious diseases.

Stability and efficacy of frozen and lyophilized fecal microbiota transplant (FMT) product in a mouse model of Clostridium difficile infection (CDI).

H. Dupont, Zhi-Dong Jiang, Evangelia Valilis, 2017, Anaerobe.

A clinical risk index for Clostridium difficile infection in hospitalised patients receiving broad-spectrum antibiotics.

L. Gentry, K. Garey, T. Dao-Tran, 2008, The Journal of hospital infection.

A common polymorphism in the interleukin-8 gene promoter is associated with an increased risk for recurrent Clostridium difficile infection.

V. Tam, K. Garey, H. Dupont, 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.